We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Greenlights Sanofi’s Prostate Cancer Drug
In a change of heart from earlier draft guidance, the UK’s National Institute for Health and Care Excellence has recommended reimbursement for Sanofi’s Jevtana for treating prostate cancer.